JAMA Dermatology

<jats:sec id="ab-dbr240026-4"><jats:title>Importance</jats:title><jats:p>Frontal fibrosing alopecia (FFA) is an inflammatory and scarring form of hair loss of increasing prevalence that most commonly affects women. An improved understanding of the genetic basis of FFA will support the identification of pathogenic mechanisms and therapeutic targets.</jats:p></jats:sec><jats:sec id="ab-dbr240026-5"><jats:title>Objective</jats:title><jats:p>To identify novel genomic loci at which common genetic variation affects FFA susceptibility and assess nonadditive effects on genetic risk between susceptibility loci.</jats:p></jats:sec><jats:sec id="ab-dbr240026-6"><jats:title>Design, Setting, and Participants</jats:title><jats:p>Four genome-wide association studies were combined using an SE-weighted meta-analysis. Within the major histocompatibility complex (MHC) locus, stepwise conditional analysis was undertaken to determine independently associated classical MHC class I alleles. Statistical tests for epistatic interaction were performed between risk alleles at the MHC and endoplasmic reticulum aminopeptidase 1 (<jats:italic>ERAP1</jats:italic>) loci.</jats:p></jats:sec><jats:sec id="ab-dbr240026-7"><jats:title>Main Outcomes and Measures</jats:title><jats:p>Genome-wide significant locus associated with FFA and nonadditive effects on genetic risk between susceptibility loci.</jats:p></jats:sec><jats:sec id="ab-dbr240026-8"><jats:title>Results</jats:title><jats:p>Of 6668 included patients, there were 1585 European female individuals with FFA and 5083 controls. Genome-wide significant associations were identified at 4 genomic loci, including a novel susceptibility locus at 5q15, and the association signal could be fine-mapped to a single nucleotide substitution (rs10045403) in the 5′ untranslated region of <jats:italic>ERAP1</jats:italic> (rs10045403; odds ratio, 1.30; 95% CI, 1.19-1.43; <jats:italic>P</jats:italic> = 3.6 × 10<jats:sup>−8</jats:sup>). Within the MHC, FFA risk was statistically independently associated with HLA-A*11:01, HLA-A*33:01, HLA-B*07:02, and HLA-B*35:01. FFA risk was affected by genetic variation at the <jats:italic>ERAP1</jats:italic> locus only in individuals who carried at least 1 of the MHC class I risk alleles.</jats:p></jats:sec><jats:sec id="ab-dbr240026-9"><jats:title>Conclusions and Relevance</jats:title><jats:p>In this genome-wide meta-analysis, a supra-additive effect of genetic variation was found that affected peptide trimming and antigen presentation on FFA susceptibility. Patients with FFA may benefit from emerging therapeutic approaches that modulate ERAP-mediated processes.</jats:p></jats:sec>

ERAP1 enzyme-mediated trimming and structural analyses of MHC I-bound precursor peptides yield novel insights into antigen processing and presentation.

J Biol Chem

The roles of ERAP1 and ERAP2 in autoimmunity and cancer immunity: new insights and perspective.

Mol Immunol

Frontal fibrosing alopecia: reflections and hypotheses on aetiology and pathogenesis.

Exp Dermatol

Lichen planopilaris and frontal fibrosing alopecia as model epithelial stem cell diseases.

Trends Mol Med

Genome-wide association study in frontal fibrosing alopecia identifies four susceptibility loci including HLA-B*07:02.

Nat Commun

Gene-environment interaction between CYP1B1 and oral contraception on frontal fibrosing alopecia.

JAMA Dermatol

EULAR study group on ‘MHC-I-opathy’: identifying disease-overarching mechanisms across disciplines and borders.

Ann Rheum Dis

Naturally occurring ERAP1 haplotypes encode functionally distinct alleles with fine substrate specificity.

J Immunol

Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Nat Genet

Oral and non-oral lichen planus show genetic heterogeneity and differential risk for autoimmune disease and oral cancer.

Am J Hum Genet

Hair follicle immune privilege and its collapse in alopecia areata.

A ‘hairy’ privilege.

Trends Immunol

Regulatory T cells in skin mediate immune privilege of the hair follicle stem cell niche.

Sci Immunol

ERAP1 deficient mice have reduced type 1 regulatory T cells and develop skeletal and intestinal features of ankylosing spondylitis.

Sci Rep

Discovery of selective inhibitors of endoplasmic reticulum aminopeptidase 1.

J Med Chem

Frontal fibrosing alopecia (FFA) is an inflammatory and scarring form of hair loss of increasing prevalence that most commonly affects women. An improved understanding of the genetic basis of FFA will support the identification of pathogenic mechanisms and therapeutic targets.
To identify novel genomic loci at which common genetic variation affects FFA susceptibility and assess nonadditive effects on genetic risk between susceptibility loci.
Four genome-wide association studies were combined using an SE-weighted meta-analysis. Within the major histocompatibility complex (MHC) locus, stepwise conditional analysis was undertaken to determine independently associated classical MHC class I alleles. Statistical tests for epistatic interaction were performed between risk alleles at the MHC and endoplasmic reticulum aminopeptidase 1 (ERAP1) loci.
Genome-wide significant locus associated with FFA and nonadditive effects on genetic risk between susceptibility loci.
Of 6668 included patients, there were 1585 European female individuals with FFA and 5083 controls. Genome-wide significant associations were identified at 4 genomic loci, including a novel susceptibility locus at 5q15, and the association signal could be fine-mapped to a single nucleotide substitution (rs10045403) in the 5' untranslated region of ERAP1 (rs10045403; odds ratio, 1.30; 95% CI, 1.19-1.43; P = 3.6 × 10-8). Within the MHC, FFA risk was statistically independently associated with HLA-A*11:01, HLA-A*33:01, HLA-B*07:02, and HLA-B*35:01. FFA risk was affected by genetic variation at the ERAP1 locus only in individuals who carried at least 1 of the MHC class I risk alleles.
In this genome-wide meta-analysis, a supra-additive effect of genetic variation was found that affected peptide trimming and antigen presentation on FFA susceptibility. Patients with FFA may benefit from emerging therapeutic approaches that modulate ERAP-mediated processes.

Epistasis of ERAP1 With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia: A Genome-Wide Association Study Meta-Analysis.

Epistasis of <i>ERAP1</i> With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia

Epistasis of <i>ERAP1</i> With 4 Major Histocompatibility Complex Class I Alleles in Frontal Fibrosing Alopecia

Clinical Summary

What was studied

Key findings

Study limitations

Related Questions